WASHINGTON, United States — Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday.
Speaking at the White House alongside Pfizer CEO Albert Bourla, Trump promised similar agreements with other drugmakers, citing the threat of tariffs as leverage.